- News
- Technical Information

- Advanced equipment and technique
- Experienced scientific team
- Highly reliable and reproducible result
- Data analysis, detailed report with results and discussion
- Quality one-stop service

News

* Please be kindly noted that our services and products can only be used for research to organizations or companies and not intended for any clinical or individuals.

Amphoteric PROTAC with Enhanced Pharmacokinetic Properties Targeting ALK

Amphoteric PROTAC with Enhanced Pharmacokinetic Properties Targeting ALK

Antiviral PROTACs

Antiviral PROTACs

Approved PROTAC Drugs

Approved PROTAC Drugs

BacPROTACs: Novel PROTACs Targeting the ClpCP

BacPROTACs: Novel PROTACs Targeting the ClpCP

Bispecific Aptamer Chimeras Degrade Target Proteins On Cell Membranes

Bispecific Aptamer Chimeras Degrade Target Proteins On Cell Membranes

Combination of Degron-based PROTACs and CAR-T

Combination of Degron-based PROTACs and CAR-T

Degrader Building Blocks for Targeted Protein Degradation

Degrader Building Blocks for Targeted Protein Degradation

Discovery of molecular glue degraders

Discovery of molecular glue degraders

Nature-CDK inhibitor CR8 acts as a molecular glue degradation agent to kill cancer cells

Nature-CDK inhibitor CR8 acts as a molecular glue degradation agent to kill cancer cells

Nature-Lysosome-targeting chimaeras for degradation of extracellular proteins

Nature-Lysosome-targeting chimaeras for degradation of extracellular proteins

Novel Intramolecular Bivalent Glue Targets Degradation of BRD4

Novel Intramolecular Bivalent Glue Targets Degradation of BRD4

Overview of 12 Targeted Protein Degradation Technologies

Overview of 12 Targeted Protein Degradation Technologies

PhosTACs Target Proteins for Dephosphorylation

PhosTACs Target Proteins for Dephosphorylation

Pro-PROTAC Development for Cancer Therapy

Pro-PROTAC Development for Cancer Therapy

PROTAC in the Generation of Live Attenuated Influenza A Virus Vaccine

PROTAC in the Generation of Live Attenuated Influenza A Virus Vaccine

PROTAC with Folate Targeting

PROTAC with Folate Targeting

Protein Degradation with New Chemical Modalities: Successful Strategies in Drug Discovery and Chemical Biology

Protein Degradation with New Chemical Modalities: Successful Strategies in Drug Discovery and Chemical Biology

Protein Degraders Targeting SARS-CoV-2 Main Protease

Protein Degraders Targeting SARS-CoV-2 Main Protease

Recent Progress of PROTACs Targeting Non-enzymatic Functional Proteins

Recent Progress of PROTACs Targeting Non-enzymatic Functional Proteins

Research Progress of Extracellular Targeted Protein Degradation Technology

Research Progress of Extracellular Targeted Protein Degradation Technology

Research Progress of p300/CBP PROTAC Degrader

Research Progress of p300/CBP PROTAC Degrader

RIBOTAC technology can target and completely degrade the genome of COVID-19

RIBOTAC technology can target and completely degrade the genome of COVID-19

RIBOTAC: RNA Degradation Technology

RIBOTAC: RNA Degradation Technology

RIPTAC Promises to Overcome Cancer Treatment Resistance

RIPTAC Promises to Overcome Cancer Treatment Resistance

Searching for molecular glue in targeted disease control

Searching for molecular glue in targeted disease control

Second-Generation PROTACs to Achieve Tumor-Specific Targeting

Second-Generation PROTACs to Achieve Tumor-Specific Targeting

Study on the permeability of androgen receptor PROTACs molecules

Study on the permeability of androgen receptor PROTACs molecules

Successful degradation of PD-L1 by Antibody-Based PROTACs Technology

Successful degradation of PD-L1 by Antibody-Based PROTACs Technology

The Development Process of DUBTAC

The Development Process of DUBTAC

The Liposome-Based PROTAC Strategy

The Liposome-Based PROTAC Strategy

We invite you to contact us at or through our contact form above for more information about our services and products.

USA

International:
US & Canada (Toll free):
Email:
Fax:

UK

Email:

Inquiry Basket

Loading ......

Delete selected Go to checkout